Actin-binding peptides: cell biology background

TB-500 is a fragment of an actin-binding protein, and the actin cytoskeleton is the context that makes the fragment interesting. This note is background on actin dynamics and the beta-thymosins for researchers reading that literature or designing in-vitro work. It describes published cell biology, not any use of any compound outside the laboratory. All Alphex products are for laboratory and in-vitro research only.

Actin, in outline

Actin exists in two interconverting forms: globular monomers (G-actin) and filaments (F-actin). Filaments are polar, growing preferentially at the barbed end and shrinking at the pointed end, and the treadmilling of subunits through them drives cell shape change, migration, division and intracellular transport. A migrating cell must polymerise actin at the leading edge and depolymerise it behind, and it must do so from a pool of monomers held ready but prevented from spontaneous nucleation. Managing that pool is the job of a set of monomer-binding proteins.

The beta-thymosins

Thymosin beta-4 (Tβ4) is the most abundant of these in many mammalian cells, present at high concentrations in platelets and leukocytes. It is a 43-residue intrinsically disordered protein that binds G-actin in a 1:1 complex, sequestering it: the bound monomer cannot polymerise, but the complex is a readily available reservoir that releases monomer as the free concentration falls. The functional consequence is a buffered monomer pool that supports rapid, localised polymerisation without uncontrolled nucleation.

Tβ4's actin-binding region centres on the sequence LKKTETQ, residues 17-23, which is the motif synthesised as TB-500. The rationale for studying the fragment is that this motif is the recognition element; the question the small fragment literature examines is how much of the parent's behaviour a seven-residue peptide can reproduce. See thymosin beta-4 versus TB-500.

Other proteins in the same system

• Profilin binds G-actin but, unlike Tβ4, delivers it to growing barbed ends, promoting rather than preventing polymerisation.
• Cofilin severs and depolymerises filaments, recycling subunits.
• The Arp2/3 complex and formins nucleate new filaments, branched and unbranched respectively.
• Capping proteins terminate elongation at barbed ends.

Any in-vitro study of a monomer-sequestering peptide sits inside this network, and interpreting an effect on "actin" without specifying which step is being measured is the commonest weakness in the secondary literature.

Typical in-vitro readouts

• Pyrene-actin polymerisation assays, where fluorescence tracks filament formation in real time, with sequestering activity appearing as a lengthened lag and reduced plateau.
• Sedimentation assays separating F- from G-actin.
• Cell migration assays (scratch/wound closure, transwell) as a downstream, multi-step readout.
• Imaging of the cytoskeleton by phalloidin staining, which reports filament organisation but not dynamics.

Practical points

• Work in molar units; the fragment (889 g/mol) and the protein (about 4,963) differ more than fivefold in mass. See calculating concentration.
• Use a scrambled-sequence control of the same composition; charge alone can affect actin assays. See controls and design.
• Purity matters here: deletion sequences of a seven-residue motif are close analogues and could bind. See 98% versus 99+%.
• Prepare fresh dilutions in low-binding plastic. See adsorption.

Alphex research peptides are supplied for laboratory and in-vitro research by qualified researchers only. They are not authorised for human or veterinary use.

Research use only. Alphex products are supplied exclusively for laboratory and in-vitro research by qualified researchers. They are not authorised for human or veterinary use, and nothing in this note is advice on any such use.

Published 17 April 2026. Alphex reviews research notes when the testing method, the catalogue or UK guidance changes.

Alphex Research Team

Alphex Limited, UK research peptide supplier

The Alphex research team writes and maintains these notes for UK laboratories buying research peptides. Every batch Alphex lists is verified by reverse-phase HPLC with a batch-matched Certificate of Analysis. Content covers laboratory and in-vitro research only.